Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Nadine C Salisch"'
Autor:
Nadine C Salisch, Marija Vujadinovic, Esmeralda van der Helm, Dirk Spek, Lars Vorthoren, Jan Serroyen, Harmjan Kuipers, Hanneke Schuitemaker, Roland Zahn, Jerome Custers, Jort Vellinga
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174728 (2017)
Durable protection against complex pathogens is likely to require immunity that comprises both humoral and cellular responses. While heterologous prime-boost regimens based on recombinant, replication-incompetent Adenoviral vectors (AdV) and adjuvant
Externí odkaz:
https://doaj.org/article/3733e047edd84080b2345657bb77a65b
Autor:
James M Billingsley, Premeela A Rajakumar, Michelle A Connole, Nadine C Salisch, Sama Adnan, Yury V Kuzmichev, Henoch S Hong, R Keith Reeves, Hyung-joo Kang, Wenjun Li, Qingsheng Li, Ashley T Haase, R Paul Johnson
Publikováno v:
PLoS Pathogens, Vol 11, Iss 3, p e1004740 (2015)
The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated macaques is delayed for 15-20 weeks, a process that is related to qualitative changes in CD8+ T cell responses induced by SIVΔnef. As a novel approach to charac
Externí odkaz:
https://doaj.org/article/5fbe518dbfca4582888711391c84f7e3
Autor:
Selina Khan, Nadine C. Salisch, Ana Izquierdo Gil, Satish Boedhoe, Karin Feddes-de Boer, Jan Serroyen, Hanneke Schuitemaker, Roland C. Zahn
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-13 (2022)
Abstract The adenovirus (Ad)26 serotype–based vector vaccine Ad26.COV2.S has been used in millions of subjects for the prevention of COVID-19, but potentially elicits persistent anti-vector immunity. We investigated if vaccine-elicited immunity to
Externí odkaz:
https://doaj.org/article/d491b13699db469ebcfbd2dc8b441508
Autor:
Juan Manuel Carreño, Jacqueline U. McDonald, Tara Hurst, Peter Rigsby, Eleanor Atkinson, Lethia Charles, Raffael Nachbagauer, Mohammad Amin Behzadi, Shirin Strohmeier, Lynda Coughlan, Teresa Aydillo, Boerries Brandenburg, Adolfo García-Sastre, Krisztian Kaszas, Min Z. Levine, Alessandro Manenti, Adrian B. McDermott, Emanuele Montomoli, Leacky Muchene, Sandeep R. Narpala, Ranawaka A. P. M. Perera, Nadine C. Salisch, Sophie A. Valkenburg, Fan Zhou, Othmar G. Engelhardt, Florian Krammer
Publikováno v:
Vaccines, Vol 8, Iss 4, p 666 (2020)
The stalk domain of the hemagglutinin has been identified as a target for induction of protective antibody responses due to its high degree of conservation among numerous influenza subtypes and strains. However, current assays to measure stalk-based
Externí odkaz:
https://doaj.org/article/b74e97729bcc4b8b9606af50e739e909
Autor:
Roland Zahn, Carlos Fierro, Maarten Leyssen, Marrit N. Habets, Kayvon Modjarrad, Rafael A. Larocca, Carla Truyers, Hanneke Schuitemaker, Leslie van der Fits, Diane G. Kanjilal, Kristi Lynn Williams, Nadine C. Salisch, Jenny Hendriks, Kathryn E. Stephenson, Macaya Douoguih, Johan Van Hoof, Dan H. Barouch, Conor P. Cahill, Freek Cox, Dirk Heerwegh, Jinyan Liu, Peter Abbink, Lauren Peter, Rafael De La Barrera
Publikováno v:
Annals of Internal Medicine. 174:585-594
BACKGROUND: Zika virus (ZIKV) may cause severe congenital disease after maternal-fetal transmission. No vaccine is currently available. OBJECTIVE: To assess the safety and immunogenicity of Ad26.ZIKV.001, a prophylactic ZIKV vaccine candidate. DESIGN
Autor:
Jan Serroyen, Dominika N. Czapska-Casey, Roland Zahn, Nadine C. Salisch, Jeroen Tolboom, L. Vorthoren, Hanneke Schuitemaker, A. Izquierdo Gil, Eirikur Saeland
Publikováno v:
npj Vaccines, Vol 4, Iss 1, Pp 1-13 (2019)
NPJ Vaccines
NPJ Vaccines
Respiratory Syncytial Virus (RSV) can cause severe respiratory disease, yet a licensed vaccine is not available. We determined the immunogenicity of two homologous and one heterologous intramuscular prime-boost vaccination regimens using replication-
Autor:
Raffael Nachbagauer, Florian Krammer, Shirin Strohmeier, Nadine C. Salisch, Tara Hurst, Eleanor Atkinson, Min Z. Levine, Boerries Brandenburg, Othmar G. Engelhardt, Alessandro Manenti, Adolfo García-Sastre, Ranawaka A.P.M. Perera, Sophie A. Valkenburg, Lethia Charles, Adrian B. McDermott, Lynda Coughlan, Teresa Aydillo, Emanuele Montomoli, Jacqueline U. McDonald, Mohammad Amin Behzadi, Peter Rigsby, Krisztian Kaszas, Leacky Muchene, Juan Manuel Carreño, Sandeep Narpala, Fan Zhou
Publikováno v:
Vaccines
Volume 8
Issue 4
Vaccines, Vol 8, Iss 666, p 666 (2020)
Volume 8
Issue 4
Vaccines, Vol 8, Iss 666, p 666 (2020)
The stalk domain of the hemagglutinin has been identified as a target for induction of protective antibody responses due to its high degree of conservation among numerous influenza subtypes and strains. However, current assays to measure stalk-based
Autor:
Roland Zahn, Jan Serroyen, Esmeralda van der Helm, Hanneke Schuitemaker, Jerome Custers, Marija Vujadinovic, Lars Vorthoren, Nadine C. Salisch, Harmjan Kuipers, Jort Vellinga, Dirk Spek
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174728 (2017)
PLoS ONE
PLoS ONE
Durable protection against complex pathogens is likely to require immunity that comprises both humoral and cellular responses. While heterologous prime-boost regimens based on recombinant, replication-incompetent Adenoviral vectors (AdV) and adjuvant
Autor:
Nadine C. Salisch, R. Paul Johnson, Gordon J. Freeman, Michael Piatak, Florencia Pereyra, Jeffrey D. Lifson, Yuan Li, David T. Evans, R. Keith Reeves, Daniel P. Tighe, Amany Awad, Daniel Kaufmann
Publikováno v:
The Journal of Immunology. 184:476-487
Ongoing antigenic stimulation appears to be an important prerequisite for the persistent expression of programmed death 1 (PD-1), an inhibitory TCR coreceptor of the CD28 family. Although recent publications have emphasized the utility of PD-1 as a m
Autor:
Peter M. Huelsmann, Karin J. Metzner, Stefanie A. Knoepfel, Pia Rauch, Nadine C. Salisch, Hauke Walter
Publikováno v:
Journal of Virology. 82:6536-6545
APOBEC3 proteins can inhibit human immunodeficiency virus type 1 (HIV-1) replication by inducing G-to-A mutations in newly synthesized viral DNA. However, HIV-1 is able to overcome the antiretroviral activity of some of those enzymes by the viral pro